Literature DB >> 3874242

Effect of sinomenine on antibody responses in mice.

H Hojo, Y Kondo, H Umeda, T Tahira, Y Hashimoto.   

Abstract

Sinomenine, an epimorphinan alkaloid, was tested for the immunosuppressive effect in mice. This compound produced a decrease of plaque-forming cells (PFC) to a T cell-dependent antigen, sheep red blood cells, in vivo. The depression of the PFC response induced with sinomenine was dose and time dependent. On the other hand, it failed to suppress the PFC response to a T cell-independent antigen, lipopolysaccharide. The immunosuppressive dose of sinomenine did not alter the cellularity of spleen, thymus, bone marrow and peripheral blood leucocytes, the DNA synthesis activity of bone marrow cells nor the proliferative responses of spleen cells induced by T cell and B cell mitogens in unprimed mice. These data suggest a selective effect of sinomenine on lymphoid cells. This compound has a potential for use in studies of immuno-deficiencies or clarifying some aspect of immunity.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3874242     DOI: 10.3109/08923978509026467

Source DB:  PubMed          Journal:  J Immunopharmacol        ISSN: 0163-0571


  3 in total

1.  Immunosuppressive effect of sinomenine in an allergic rhinitis mouse model.

Authors:  Zhe Chen; Ze-Zhang Tao; Xu-Hong Zhou; Ting-Ting Wu; Lin-Feng Ye
Journal:  Exp Ther Med       Date:  2017-03-20       Impact factor: 2.447

2.  Effect of sinomenine on vascular smooth muscle cell dedifferentiation and neointima formation after vascular injury in mice.

Authors:  Lihua Zhu; Yarong Hao; Hongjing Guan; Changping Cui; Song Tian; Da Yang; Xinan Wang; Shuming Zhang; Lang Wang; Hong Jiang
Journal:  Mol Cell Biochem       Date:  2012-10-13       Impact factor: 3.396

3.  Sinomenine protects against lipopolysaccharide-induced acute lung injury in mice via adenosine A(2A) receptor signaling.

Authors:  Jun Li; Li Zhao; Xie He; Yi-Jun Zeng; Shuang-Shuang Dai
Journal:  PLoS One       Date:  2013-03-15       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.